South Africa Publishes Draft Intellectual Property Policy With Potential Effects For Pharma Patents

“South Africa’s government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs,” Agence France-Presse reports. “If accepted, the reforms will facilitate the production of cheaper, generic medicines, according to Doctors Without Borders (MSF) and local AIDS-activist group Treatment Action Campaign,” AFP writes, adding, “The policies ‘set the stage for changes that promise to increase competition in the pharmaceutical sector and lower the price of medicines in South Africa,’ the groups said in a statement.” The news service notes, “South Africa’s current laws allow firms to renew patents indefinitely by changing minute elements in a medicine’s composition,” while “[t]he new patent policies will allow the production of generic medicines and grant over five million South Africans living with AIDS or multidrug-resistant (MDR) tuberculosis access to treatments” (9/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.